GleamWall
中文EN

BWAY Brainsway Ltd. IFRS

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1505065

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY29.0%
TTM net income YoY169.6%
TTM EPS YoY138.5%
Revenue 3-yr CAGR11.4%
Net income 3-yr CAGR—

Margins

Gross margin74.6%
Operating margin3.4%
Net margin7.1%
FCF margin—
EBITDA margin5.0%

Returns

ROE5.6%
ROA3.7%
ROIC (approx.)9.8%
Asset turnover0.52x

Leverage & solvency

Liabilities / assets33.9%
Debt / equity0.00x
Current ratio5.19x
Interest coverage0.92x

Cash quality & payout

Operating cash flow / net income3.53x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2020Q4*2020-12-312019Q4*2019-12-31
Income statement
Revenue$7.07M$6.29M
Cost of revenue$1.57M$1.44M
Gross profit$5.50M$4.85M
R&D expense$1.58M$1.81M
SG&A expense$1.33M$1.43M
Operating income-$9.25M-$14.96M
Interest expense$239,000$178,000
Pretax income-$9.65M-$17.64M
Income tax-$240,000$147,000
Net income-$406,000-$2.32M
EBITDA-$9.02M-$14.62M
EPS (diluted)——
Balance sheet
Cash & equivalents$16.96M$21.67M
Receivables$5.58M$5.51M
Current assets$24.30M$28.83M
PP&E, netmay include right-of-use assets (IFRS)$4.35M$4.25M
Total assets$34.01M$38.74M
Current liabilities$6.80M$6.72M
Total liabilities$14.38M$14.52M
Shareholders' equity$19.63M$24.22M
Shares outstanding22.25M22.24M
Cash flow statement
Operating cash flow$1.64M-$1.23M
Capital expenditure-$85,000$338,000
Free cash flow$1.73M-$1.57M
Investing cash flow$85,000-$396,000
Financing cash flow-$750,000-$414,000
Depreciation & amortization$228,000$340,000
Stock-based compensation$128,000$282,000

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.